20124586

Source:http://linkedlifedata.com/resource/pubmed/id/20124586

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0034975, umls-concept:C0038257, umls-concept:C0041703, umls-concept:C0733511, umls-concept:C1274040, umls-concept:C1709854
pubmed:issue	2
pubmed:dateCreated	2010-2-3
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00245401
pubmed:abstractText	To examine the 1-year safety and clinical outcomes associated with the post-marketing early unselected use of sirolimus-eluting stents (SES) in the United States.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20124586-20124587
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8917477
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1557-2501
pubmed:author	pubmed-author:BergerPeterP, pubmed-author:BezerraHiramH, pubmed-author:BlockPeterP, pubmed-author:BrittoSuzanneS, pubmed-author:CohenSidneyS, pubmed-author:CostaMarcoM, pubmed-author:DippelEricE, pubmed-author:KatzStanleyS, pubmed-author:KelletMirleM, pubmed-author:PerinEmersonE, pubmed-author:RameeStephenS, pubmed-author:SchaerGaryG
pubmed:issnType	Electronic
pubmed:volume	22
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	48-55
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:20124586-Aged, pubmed-meshheading:20124586-Angioplasty, Balloon, Coronary, pubmed-meshheading:20124586-Coronary Artery Disease, pubmed-meshheading:20124586-Coronary Restenosis, pubmed-meshheading:20124586-Diabetes Mellitus, Type 1, pubmed-meshheading:20124586-Drug-Eluting Stents, pubmed-meshheading:20124586-Female, pubmed-meshheading:20124586-Fibrinolytic Agents, pubmed-meshheading:20124586-Follow-Up Studies, pubmed-meshheading:20124586-Humans, pubmed-meshheading:20124586-Immunosuppressive Agents, pubmed-meshheading:20124586-Male, pubmed-meshheading:20124586-Middle Aged, pubmed-meshheading:20124586-Myocardial Infarction, pubmed-meshheading:20124586-Off-Label Use, pubmed-meshheading:20124586-Product Surveillance, Postmarketing, pubmed-meshheading:20124586-Quality Control, pubmed-meshheading:20124586-Randomized Controlled Trials as Topic, pubmed-meshheading:20124586-Registries, pubmed-meshheading:20124586-Sirolimus, pubmed-meshheading:20124586-Treatment Outcome, pubmed-meshheading:20124586-United States
pubmed:year	2010
pubmed:articleTitle	Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry.
pubmed:affiliation	University Hospitals Case Medical Center, Cardiovascular Dept., Cleveland, OH 44106-6031, USA.
pubmed:publicationType	Journal Article, Comment